Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/OZTA stock hub

FRA/OZTA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/OZTAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
5.6B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/OZTA
In the news

Latest news · FRA/OZTA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.5
P25 n/aP50 n/aP75 n/a
Trailing P/E13.4
P25 n/aP50 n/aP75 n/a
ROE6.1
P25 n/aP50 n/aP75 n/a
ROIC6.7
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/OZTA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
218
Groups with data
11
Currency
EUR
Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Spain
Country code
DE
Employees
25,258
Employees Change
800%
Employees Change Percent
3.48
Enterprise value
EUR 16.9B
Exchange
Frankfurt Stock Exchange
Financial currency
EUR
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 5.6B
Price
EUR 8.84
Price currency
EUR
Rev Per Employee
297,520x
Sic
2836
Symbol
fra/OZTA
Website
https://www.grifols.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
7.47%
EV Earnings
40.75x
EV/EBIT
12.24x
EV/EBITDA
9.62x
EV/FCF
22.46x
EV/Sales
2.27x
FCF yield
13.56%
Forward P/E
8.55x
P/B ratio
0.71x
P/E ratio
13.39x
P/S ratio
0.75x
PE Ratio10 Y
46.3x
PE Ratio3 Y
69.86x
PE Ratio5 Y
69.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
18.58%
EBITDA Margin
22.54%
FCF margin
10.12%
Gross margin
38.36%
Gross Profit
EUR 2.9B
Gross Profit Growth
-1.74%
Gross Profit Growth Q
-9.31%
Gross Profit Growth3 Y
7.59%
Gross Profit Growth5 Y
5.36%
Net Income
EUR 415M
Net Income Growth
112.57%
Net Income Growth Q
22.23%
Net Income Growth3 Y
107.13%
Net Income Growth5 Y
-5.89%
Pretax Margin
8.21%
Profit Margin
5.58%
Profit Per Employee
EUR 16,600
ROA
4.21
Roa5y
2.87
ROCE
7.7
ROE
6.13
Roe5y
3.59
ROIC
6.74
Roic5y
4.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr10y
-6.31%
Cagr15y
2.37%
Cagr1y
8.47%
Cagr3y
0.1%
Cagr5y
-17.1%
Div CAGR10
-5.65%
Div CAGR3
-34.18%
Div CAGR5
-1.48%
EPS Growth5 Y
-5.74
FCF Growth
-21.47%
FCF Growth Q
-32.81%
FCF Growth5 Y
-3.74%
OCF Growth
-15.1%
OCF Growth Q
-18.8%
OCF Growth10 Y
2.9%
OCF Growth5 Y
-2.9%
Revenue Growth
0.89x
Revenue Growth Q
-4.81x
Revenue Growth3 Y
5.37x
Revenue Growth5 Y
7.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.36
Assets
EUR 20.1B
Cash
EUR 702M
Current Assets
EUR 5.3B
Current Liabilities
EUR 2.1B
Debt
EUR 9.7B
Debt EBITDA
EUR 5.5
Debt Equity
EUR 1.23
Debt FCF
EUR 12.84
Equity
EUR 7.8B
Interest Coverage
2.46
Liabilities
EUR 12.2B
Long Term Assets
EUR 14.8B
Long Term Liabilities
EUR 10.1B
Net Cash
EUR -9B
Net Cash By Market Cap
EUR -161
Net Debt EBITDA
EUR 5.35
Net Debt Equity
EUR 1.14
Net Debt FCF
EUR 11.91
Tangible Book Value
EUR -5.2B
Tangible Book Value Per Share
EUR -7.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.47
Inventory Turnover
1.31
Net Working Capital
EUR 3B
Quick ratio
0.78
Working Capital
EUR 3.1B
Working Capital Turnover
EUR 2.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
EUR 0.12
Dividend Years
1
Dividend Yield
1.37%
Ex Div Date
2025-08-11
Last Dividend
EUR 0.12
Payout Frequency
Annual
Payout Ratio
30.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
-47.91%
1Y total return
8.47%
200-day SMA
10.92
3Y total return
0.3%
50-day SMA
9.31
50-day SMA vs 200-day SMA
50under200
5Y total return
-60.84%
All Time High
34.31
All Time High Change
-74.23%
All Time High Date
2020-02-20
All Time Low
2.39
All Time Low Change
269.87%
All Time Low Date
2006-05-25
ATR
0.16
Ch YTD
-18.75
High
9.02
High52
13.42
High52 Date
2025-07-31
High52ch
-34.1%
Low
8.84
Low52
8.05
Low52 Date
2025-05-12
Low52ch
9.87%
Ma50ch
-5.02%
Price vs 200-day SMA
-19.06%
RSI
43.77
RSI Monthly
43.23
RSI Weekly
36.84
Sharpe ratio
0.33x
Sortino ratio
0.7
Total Return
1.37%
Tr YTD
-18.75
Tr15y
42.16%
Tr1m
-6.08%
Tr1w
0.16%
Tr3m
-17.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 1.4B
Operating Income Growth
0.83
Operating Income Growth Q
-4.51
Operating Income Growth3 Y
34.49
Operating Income Growth5 Y
8.79
Operating margin
18.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
417,315,300%
Net Borrowing
-272,000,000
Shares Insiders
2.14%
Shares Institutions
46.48%
Shares Qo Q
0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
EUR 753M
Average Volume
55.75x
Bv Per Share
8.02
CAPEX
EUR -268M
Ch10y
-51.68
Ch15y
28.12
Ch1m
-6.08
Ch1w
0.16
Ch1y
7.44
Ch3m
-17.19
Ch3y
-0.65
Ch5y
-61.72
Ch6m
-14.92
Change
-1.1%
Change From Open
-2
Close
8.94
Days Gap
0.89
Depreciation Amortization
294,000,000
Earnings Date
2026-05-07
EBIT
EUR 1.4B
EBITDA
EUR 1.7B
EPS
EUR 0.61
F Score
6
FCF
EUR 753M
FCF EV Yield
4.45x
Financing CF
-501,000,000
Fiscal Year End
December
Founded
1,909
Graham Number
13.62186
Graham Upside
54.09
Income Tax
EUR 116M
Investing CF
-523,000,000
Is Primary Listing
0
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Last Split Date
2016-01-04
Last Split Type
Forward
Lynch Fair Value
EUR 3.3
Lynch Upside
-62.65
Ma150
10.46
Ma150ch
-15.51%
Ma20
9.02
Ma20ch
-2.01%
Net CF
-51,000,000
Open
9.02
P FCF Ratio
7.38
P OCF Ratio
5.44
Payment Date
2025-08-13
Position In Range
0
Ppne
3,163,000,000
Price Date
2026-05-08
Price EBITDA
EUR 3.31
Relative Volume
1.8x
Revenue
7,438,000,000x
Tax By Revenue
1.56x
Tax Rate
18.99%
Tr6m
-14.92%
Volume
0
Z Score
1.11
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

FRA/OZTA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.4%
$0.12 annual per share
Payout ratio
+30.8%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-1.5%
0 consecutive years of growth
Total shareholder yield
+1.4%
Next ex-dividend date: 2025-08-11
Performance

FRA/OZTA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+8.5%
S&P 500 1Y: n/a
3Y total return
+0.3%
S&P 500 3Y: n/a
5Y total return
-60.8%
S&P 500 5Y: n/a
10Y total return
-47.9%
S&P 500 10Y: n/a
Ownership

Who owns FRA/OZTA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+46.5%
Share of float held by funds and institutions
Insider ownership
+2.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

FRA/OZTA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
43.8
Neutral momentum band
Price vs 200-day MA
-19.1%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.33
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/OZTA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/OZTA stock rating?

fra/OZTA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/OZTA analysis?

The full report lives at /stocks/fra/OZTA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/OZTA?

The latest report frames fra/OZTA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/OZTA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/OZTA stock profile: metrics, valuation and analysis | 股票市场 AI 助手